Welcome to Taking Control Of Your Diabetes® - The Podcast, an edutaining show all about highs and lows of living with diabetes. Hosted by Dr. Steve Edelman and Dr. Jeremy Pettus, both endocrinologists who have been living with diabetes themselves since they were 15, we’re discussing the important topics that people living with diabetes need to know—and no topic is off-limits. From the latest advancements in diabetes medications and devices, to interviews with some of the best minds in diabetes, to personal stories about the ups and downs of dealing with this condition 24/7, we’re tackling what it means to live with diabetes in modern times. And we promise to make you laugh along the way, because sometimes we just need to laugh at the craziness that comes with living with diabetes. Tune in for a new episode on the last Monday of every month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes! VISIT: tcoyd.org | FOLLOW: tcoyd.org/contact | EMAIL: podcast@tcoyd.org APPLE PODCAST RATING: 4.9/🌟🌟🌟🌟🌟
In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus are joined by Dr. Shara Bialo, Senior Medical Director of Type 1 Diabetes Immunology at Sanofi, pediatric endocrinologist, and person living with type 1 diabetes, for an in-depth discussion about what happens before type 1 diabetes is diagnosed . Together, they explore the autoimmune process that begins months or even years before symptoms appear, why early detection matters, and how screening is changing the future of type 1 diabetes care . Dr. Bialo shares her personal diagnosis story, discusses common misconceptions about what causes type 1 diabetes, and explains the three stages of the disease. The conversation also covers who should be screened, how diabetes autoantibody testing works, the benefits of preserving beta cell function, and why identifying people before they develop symptoms can lead to better long-term outcomes and fewer cases of diabetic ketoacidosis (DKA). Whether you have type 1 diabetes, have a family member at risk, or simply want to better understand the latest advances in prevention and early detection, this episode provides valuable insights into one of the fastest-moving areas of diabetes research. Key Topics: Dr. Shara Bialo's personal journey living with type 1 diabetes Why type 1 diabetes is an autoimmune disease, not simply a blood sugar problem The role of genetics, viral infections, and the immune system Understanding the three stages of type 1 diabetes Why most people diagnosed with type 1 diabetes have no family history Adult-onset type 1 diabetes and why it is often mistaken for type 2 diabetes What diabetes autoantibodies are and how screening works Who should consider screening for type 1 diabetes Available screening options, including blood tests and home screening kits The emotional challenges families face when considering screening The importance of preventing diabetic ketoacidosis through early detection Why preserving beta cell function can improve long-term outcomes Italy's national screening program and the future of population-wide screening Resources available through screenfortype1.com This content was produced with support from Sanofi and screenfortype1.com . ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by Raquel Baron , founder of Type One Together , to discuss the challenges, triumphs, and everyday realities of raising a child with type 1 diabetes. Diagnosed herself at age five, Raquel combines her lived experience with years of supporting families through Type One Together, an organization that provides trusted resources, educational programs, and a nationwide network of trained babysitters for children with type 1 diabetes. Together, Dr. Edelman and Raquel explore the emotional side of diabetes that often goes beyond blood sugars . They discuss helping children navigate school, sports, friendships, burnout, and growing independence, while giving parents practical strategies to reduce fear, build confidence, and create a healthier relationship with diabetes. The conversation also covers diabetes technology, social media, Afrezza for children, community support, and why perfection should never be the goal. Whether you’re the parent of a newly diagnosed child or have been managing type 1 diabetes for years, this episode offers practical advice, reassurance, and reminders that children with diabetes can live full, active lives . ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by pediatric endocrinologist Dr. Anna Cymbaluk, along with Philip and his father Jim, to discuss the recent FDA approval of Afrezza inhaled insulin for children and adolescents living with type 1 diabetes. Dr. Cymbaluk served as an investigator on the INHALE-1 trial, while Philip participated in the study himself, providing a unique real-world perspective on what it is like to transition from injections to inhaled insulin , and Philip’s dad, Jim provided the parent perspective as well as addressed parental concerns that might have arisen. The conversation focuses on the INHALE-1 study and the unmet challenges that continue to exist around mealtime insulin dosing in pediatric diabetes care. Dr. Cymbaluk reviews the trial design, glucose outcomes, safety data, patient satisfaction findings, and the practical realities of introducing inhaled insulin into everyday diabetes management. Philip and Jim share how Afrezza impacted school, sports, social situations, and the day-to-day burden of diabetes, particularly around pre-bolusing, corrections, and avoiding multiple injections throughout the day. Dr. Edelman and Dr. Cymbaluk also explore how Afrezza is dosed, how inhaled insulin differs from injected insulin, who may be a good candidate, and where it may fit alongside pumps and automated insulin delivery (AID) systems. For families looking for more flexibility, fewer mealtime barriers, and another option in the diabetes toolbox, this episode provides an honest look at the benefits, limitations, and real-world experience of inhaled insulin in children and teens. Key Topics • The FDA approval of Afrezza for children and adolescents living with type 1 diabetes • The design and results of the INHALE-1 pediatric clinical trial • Patient satisfaction and quality-of-life outcomes from the study • The challenges of pre-bolusing and mealtime insulin management in children and teens • How inhaled insulin compares to traditional mealtime injections • Dosing strategies, cartridge sizes, and insulin conversion considerations • Using Afrezza for corrections, meals, and post-meal dosing • The role of continuous glucose monitoring (CGM) when using inhaled insulin • Safety findings, lung-function monitoring, and cough management • Who may be a good candidate for Afrezza—and who may not be • Benefits for active children, athletes, and those participating in sports • Social situations, injection avoidance, and reducing the burden of diabetes management • Using Afrezza alongside insulin pumps and automated insulin delivery (AID) systems • The importance of having more treatment options to individualize diabetes care Supported by an unrestricted educational grant from MannKind Corporation Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
In this episode of the TCOYD Podcast, Drs. Edelman and Pettus are joined by pediatric endocrinologist Dr. Jamie Wood, medical director of pediatric diabetes at Rainbow Babies & Children's Hospital and an investigator on the INHALE-1 trial, to discuss inhaled insulin in children and its place in pediatric practice. The conversation centers on the recent approval of Afrezza down to age six and what INHALE-1 actually demonstrated. Dr. Wood walks through the trial design, the A1C analysis, the FEV1 and pulmonary safety data, the weight and BMI findings, and the practical mechanics of dosing in a pediatric population. Rather than framing it as a replacement for injections or automated insulin delivery (AID), the discussion focuses on where this option fits, from the needle-averse newly diagnosed patient, to the teen trying to bolus discreetly during a 20-minute lunch period. Drs. Edelman, Pettus, and Wood also get into the clinical realities that shape real-world use: the 2:1 to 3:1 conversion versus subcutaneous insulin, the set-dose cartridges and how they reframe carb counting, a refined titration approach, side effects, and how inhaled insulin can be layered alongside pumps and AID. For a population where mealtime bolusing remains one of the most stubborn unmet needs, it is a grounded look at a new tool and the patients it may help most. Key Topics The recent approval of inhaled insulin for children as young as six How the INHALE-1 pediatric trial was designed A1C results and what the primary endpoint analysis showed Continuous glucose monitor (CGM) metrics across the two groups Lung-function (FEV1) monitoring and pediatric safety Weight and body mass index (BMI) findings Why mealtime dosing is a leading unmet need in pediatric type 1 diabetes (T1D) The set-dose cartridge approach and how it reframes meal sizes A real-world titration method for inhaled insulin Managing cough and other practical considerations Needle phobia and the kids who struggle most with injections Using inhaled insulin alongside automated insulin delivery (AID) systems What's coming next, including a smaller cartridge dose and a new-onset trial This episode is supported by an unrestricted educational grant from MannKind Corporation. Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
What diabetes technology is actually helping people right now—and how do you figure out what fits best into your life? In this 100th episode of the TCOYD Podcast, Dr. E and Dr. P are joined by diabetes nurse practitioner and educator Rachael Sood, founder of The Diabetes Collective, to talk through the latest updates in diabetes technology and what they’re seeing in real-world diabetes care. The conversation focuses on how much diabetes technology has changed over the past few years, from hybrid closed loop systems and CGMs to new developments in sensing and automation. Rather than focusing on one “best” device, the discussion centers around finding the right fit for each person’s lifestyle, preferences, and goals. Dr. E, Dr. P, and Rachael also talk about where technology may be headed next, including dual glucose and ketone sensors, more compatibility between pumps and CGMs, and the possibility of systems that require less hands-on work from people living with diabetes. The takeaway is encouraging: there are more tools and options than ever before, and diabetes technology continues to move toward making daily management simpler, safer, and more flexible. Key Topics • Choosing the right insulin pump and CGM • Tubed vs. tubeless pump systems • How lifestyle and personal preference shape technology choices • The latest updates in automated insulin delivery systems • Dexcom G7 10-day vs. 15-day sensors • Abbott’s dual glucose and ketone sensor technology • Medtronic’s newest technology developments • Real-world conversations patients have about wearing devices • Continuous ketone monitoring and DKA prevention • The future of fully closed loop systems • Why compatibility between pumps and CGMs matters • Technology options for people with type 2 diabetes • Where diabetes technology may be headed next ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
What if something was going on with your health and you didn’t feel any symptoms at all? Could it be metabolic dysfunction-associated steatohepatitis (MASH)? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus talk about fatty liver and MASH, a condition that can develop quietly but still has a real impact over time. They’re joined by patient advocate Manuel Oliver, who shares his experience after being diagnosed and what helped him turn things around. They explain why fatty liver is so common, especially in people with metabolic conditions, and why it often goes unnoticed. The conversation also highlights how things can change over time, even when you feel okay, and why routine checkups matter. Manuel shares what it was like to hear his diagnosis, how it affected him, and the steps he took to improve his health. You’ll also hear how care has evolved, including better ways to detect liver disease and more options to support treatment alongside lifestyle changes. The message is simple: this condition can be serious, but there are ways to manage it, and taking action can make a meaningful difference. ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
What does it really mean to be “gluten-free” and how do you know if it’s something you actually need?In this episode, Dr. Steve Edelman sits down with registered dietitian EA Stewart (aka The Spicy RD) to talk through the difference between celiac disease and gluten sensitivity, and why that distinction matters. They explain how celiac disease develops, why it’s often missed, and how it connects to other autoimmune conditions like type 1 diabetes. This conversation helps make sense of a topic that can feel confusing. Dr. E and EA walk through symptoms that go beyond digestion, the importance of getting tested the right way, and what it means to truly follow a gluten-free diet. They also talk about the day-to-day side of things—how to approach food, avoid cross-contamination, and build a way of eating that works in real life. The main takeaway: not everyone needs to avoid gluten, but if you do, understanding the reason behind it can make it a lot more manageable Key Topics • What celiac disease is and how it differs from gluten sensitivity • The role of genetics, triggers, and gluten exposure • Why celiac disease is often undiagnosed • Common and less obvious symptoms • The connection between celiac disease and type 1 diabetes • How to properly test for celiac disease • Why you need to be eating gluten before testing • What a gluten-free diet actually looks like • Naturally gluten-free foods and better alternatives • Hidden sources of gluten in everyday foods • Cross-contamination and why it matters • Nutrient deficiencies and when supplements may help • Tips for eating out and traveling ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
What if a type 2 diabetes diagnosis could be the start of taking better care of your health—not the end of it? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus share their top 10 tips for people newly diagnosed with type 2 diabetes, with a focus on helping you feel informed, supported, and encouraged. They talk about why this diagnosis is not a personal failure, how much of it is connected to genetics and metabolism, and why early understanding can make a meaningful difference. The conversation is grounded, hopeful, and focused on what’s possible. Steve and Jeremy walk through simple, realistic steps that can help you feel more in control—without pressure to be perfect. They cover everything from understanding how your body works to building habits that fit into your everyday life, along with the growing number of tools and treatments that can support you along the way. The takeaway is clear: this diagnosis can feel overwhelming at first, but it can also be a turning point. With time, support, and the right approach, you can improve your health and continue living a full, active life. Key Topics • Why type 2 diabetes is not your fault • Understanding insulin resistance and disease progression • Why early action matters • Focusing on weight with realistic expectations • The role of GLP-1 medications in early treatment • Exercise and movement as part of daily life • Learning how food affects your body • Using blood sugar monitoring in a practical way • Taking medications consistently • Protecting your heart early • The importance of routine screenings and labs • Building a strong and supportive care team ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
What does someone really need to know in the first days and weeks after a type 1 diabetes diagnosis? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus share the “starter kit” they wish every newly diagnosed person and family had from the very beginning . Both diagnosed with type 1 diabetes at age 15, Steve and Jeremy reflect on what has changed since their own diagnoses and walk through the practical advice, emotional reassurance, and foundational education that can make this transition a little less overwhelming. The conversation covers everything from the normal emotional reaction to a diagnosis, to the importance of early diabetes education, getting started with insulin, using CGM as soon as possible, and setting realistic blood sugar goals . They also talk about the honeymoon phase, how to keep doing the things you love, why support systems matter, how to find the right provider, and what newly diagnosed families should know about clinical trials and preserving beta cell function. This episode is a reminder that while a new diagnosis can feel like your world has been turned upside down, people with type 1 diabetes can live long, healthy, full lives—and that no one has to figure it all out alone. Key Topics • Why it’s okay to feel overwhelmed after diagnosis • The importance of diabetes education right away • Understanding the honeymoon phase • Basal and bolus insulin basics • Why CGM should be started early • Realistic A1C and time-in-range goals • Keeping up with the things you love • Involving family, friends, and support networks • Finding the right diabetes provider • Considering clinical trials after diagnosis • Food, carb counting, and keeping things simple • Staying positive and looking ahead ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
Are you getting the most out of the diabetes technology you use every day and do you know what’s coming next? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with diabetes tech expert Justin Eastzer, creator of Diabetech , who is also living with type 1 diabetes, for a conversation about the steadily growing and expanding world of diabetes technology. They talk about how CGMs, automated insulin delivery systems, connected apps, and wearable displays are continuing to improve the way people with type 1 diabetes manage glucose in daily life . Justin shares his diagnosis story, including being initially treated for type 2 diabetes before learning he had type 1, and how the online diabetes community helped him find the right answers. That experience led him to build a platform dedicated to reviewing devices, following industry developments, and helping people better understand the technology available today . The discussion explores the current landscape of automated insulin delivery systems, practical differences between pumps, and the growing ecosystem of apps, displays, and data tools that allow people to interact with their glucose data in real time. They also look ahead at what’s coming next in diabetes tech, including new pump designs, smarter algorithms, improved connectivity, and continued efforts to reduce the day-to-day workload of living with type 1 diabetes. Key Topics • Why many people only use part of their diabetes tech’s capabilities • Justin’s journey to a type 1 diabetes diagnosis • Making pumps, CGMs, and apps work in everyday life • Comparing automated insulin delivery systems • Tubed vs. tubeless pump considerations • The importance of optimizing personal settings • Progress over perfection with time in range • Reducing diabetes burnout through technology • Helpful apps, displays, and tech hacks • Where diabetes technology is heading next ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
What does it really look like to grow older with type 1 diabetes today? The good news is people with diabetes are now living longer than ever! In this episode, Dr. Steve Edelman is joined by diabetes advocate Joanne Milo and endocrinologist Dr. Athena Tsimikas to talk about the realities of aging with type 1 . They share how expectations have changed over time, why more people are now living long lives with diabetes, and what it takes to stay safe, independent, and supported through the aging process. The conversation covers changing insulin needs, screening for vision, hearing, and cognitive health, the role of technology, and the importance of community and care partners . They also discuss the emotional side of aging with diabetes, including the need to feel heard, understood, and safe while continuing to live a full and meaningful life. Key Topics • Living longer with type 1: how expectations have changed • Changing insulin sensitivity, muscle mass, and dosing over time • Preventing falls: vision, neuropathy, and mobility considerations • Cognitive health and why screening matters • Technology in older adults: CGM and hybrid closed-loop benefits • Medication considerations for heart and kidney protection • The role of care partners and support systems • Emotional health: fear, independence, and being understood • Staying active, social, and engaged while aging with diabetes • Advocacy and preparing for the future ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
What does it take to safely manage type 1 diabetes while flying a commercial jet? In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman talk with Quinton Weiskittel, a commercial pilot living with type 1 diabetes . Quinton shares what it was like to be diagnosed mid-career, how FAA rules have changed, and the real-world routines he uses to stay steady through long flights, time zones, busy airports, and long stretches of sitting. They also cover what the FAA requires for certification , how Quinton uses CGM data and smart “buffer” strategies to prevent lows , and why he’s chosen MDI over pump therapy while flying. Key Topics Being diagnosed with diabetes mid-career: the moment everything changed FAA rules on pilots with diabetes and the path back to the cockpit CGM targets, reporting requirements, and medical follow-ups as a pilot with diabetes Preventing lows during flights: alerts, trends, and planning ahead Food choices and low-carb strategies while flying a plane What coworkers need to know (CGM alarms, injections, and professionalism) Travel tips for diabetes: airports,travel lulls and wait time, and insulin logistics Pump therapy in the air: pressure concerns and practical tradeoffs Advocacy and finding the right endocrinology support Life perspective: staying grounded while chasing big goals ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
What exactly is inflammation, and how do you know if it's affecting your health? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus sit down with Dr. Jennie Luna, an endocrinologist specializing in obesity medicine and nutrition, to demystify inflammation and its connection to diabetes and metabolic health. Together, they explore the difference between acute and chronic inflammation, why chronic inflammation often goes unnoticed despite affecting nearly every organ system, and how it drives conditions like insulin resistance, fatty liver disease, and chronic kidney disease. Dr. Luna breaks down the warning signs—fatigue, brain fog, difficulty sleeping, and weight gain—and explains why these symptoms are so easy to miss. The conversation shifts to actionable strategies you can implement today. From anti-inflammatory eating patterns and time-restricted eating to managing stress and prioritizing sleep, this episode focuses on practical, realistic changes that don't require perfection or meal prep mastery. Key Topics Understanding Inflammation: The difference between acute and chronic inflammation and why chronic inflammation silently impacts metabolic health. Signs You Might Be Inflamed: Recognizing vague symptoms like fatigue, mental fog, and disrupted sleep that often go undiagnosed. Inflammation and Diabetes: How insulin resistance, high blood sugar, and inflammation create a vicious cycle—and how to break it. Anti-Inflammatory Eating Made Simple: Practical food strategies including protein-first meals, time-window eating, and budget-friendly swaps. The Fast Food Reality: Honest talk about convenience eating and how to make better choices when time is tight. Beyond Diet: Why sleep quality, stress management, and even 10-minute post-meal walks have powerful anti-inflammatory effects. GLP-1s and Inflammation: Emerging research showing these medications may reduce inflammation independent of weight loss. The Bottom Line: Why small, sustainable changes—not perfection—are the key to reducing inflammation and improving overall health. [00:00:23] - Introduction: What is inflammation? [00:00:45] - Welcome to the Taking Control of Your Diabetes Podcast [00:01:23] - Special Guest: Dr. Jennie Luna (Endocrinology & Obesity Medicine) [00:02:55] - Acute vs. Chronic Inflammation [00:03:40] - The "Stingray" Incident: A Lesson in Acute Inflammation [00:04:07] - Pro-Tip: How to do the "Stingray Shuffle" [00:05:05] - Identifying the Signs and Symptoms of Chronic Inflammation [00:07:09] - The Vicious Cycle: Inflammation and Insulin Resistance [00:08:13] - Metabolic Syndrome: Heart, Liver, and Kidney Health [00:09:24] - Why Weight Loss is the Ultimate Anti-Inflammatory [00:10:41] - Silent Triggers: Stress, Lack of Sleep, and Diet [00:12:33] - High-Yield Diet Tips: The "Protein First" Rule [00:13:28] - Time-Window Eating and Intermittent Fasting [00:15:29] - Is Healthy Eating Actually More Expensive? [00:17:25] - Realistic Habit Changes and Success Markers [00:19:53] - The Great Egg Debate: Protein vs. Cholesterol [00:21:58] - Practical Tips: Meal Prep and Chia Seed Pudding [00:25:35] - The Anti-Inflammatory Future: GLP-1s and New Research [00:27:34] - Stress Management and the Dopamine "Reward Circuit" [00:29:07] - The Link Between Sleep Apnea and Inflammation [00:30:07] - Sleep Hygiene: Removing Blue Light and Doom Scrolling [00:31:38] - The Power of Exercise and the 10-Minute Post-Meal Walk [00:32:17] - Conclusion and Final Takeaways ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
What new advancements are actually coming in diabetes care in 2026 and what’s in store in the near future? In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus both take a look at the diabetes treatments and technologies they believe are most likely to arrive in 2026. Together, they walk through emerging therapies for both type 1 and type 2 diabetes, focusing on developments that are no longer theoretical but actively moving through late-stage trials and regulatory review. The conversation covers disease-modifying treatments, next-generation medications, and technology advances that could meaningfully change daily diabetes management. Key Topics: • Disease-Modifying Therapies for T1D: Preserving beta cell function after T1D diagnosis and why this represents a major shift in treatment goals. • New Medications for Type 2 Diabetes: Oral GLP-1s, dual- and triple-agonist therapies, and what they may offer beyond current options. • GLP-1s in Type 1 Diabetes: Where the research stands, off-label use today, and what future approvals could look like. • Once-Weekly Basal Insulin: Why it’s promising for type 2 diabetes and who it’s best suited for. • Inhaled Insulin Updates: New dosing guidance and expanded use cases. • Continuous Ketone Monitoring: How this technology could improve safety and open doors for additional therapies in T1D. • Cure-Oriented Research: Stem cell and gene therapy approaches that aim to restore insulin production. • The Big Picture in 2026: Why 2026 represents real momentum — and what it could mean for access, outcomes, and quality of life. We also created an article on this topic - READ IT HERE ! ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
Why did the FDA deny sotagliflozin —even with strong data showing heart, kidney, and glucose benefits? In this episode, Dr. Steve Edelman sits down with special guest Stacey Simms to break down the full story behind SGLT inhibitors and their complicated path in type 1 diabetes. Together, they walk through how SGLT inhibitors transformed type 2 diabetes care, why many clinicians believe people with type 1 should have access, and how the risk of DKA shaped the FDA’s decision . Dr. Edelman also shares insights on who might benefit, how to reduce risk, and why continuous ketone monitoring could be a game-changer for future approvals. They also touch on the growing discussion around GLP-1 medications in type 1 diabetes, new study results, and what emerging evidence could mean for future treatment options. In this episode: • Sotagliflozin & SGLT Inhibitors in T1D: Why these medications matter and what the latest data shows. • The FDA Denial: Understanding the DKA concerns and why approval remains challenging. • Real-World Experience: How clinicians are using SGLT inhibitors safely today in select patients. • Continuous Ketone Monitoring: Why dual-analyte sensors could unlock safer use in T1D. • GLP-1s in Type 1 Diabetes: What recent research reveals about potential benefits. • Who Might Benefit Most: Kidney protection, heart health, and metabolic improvements. • Looking Ahead: How ongoing studies and patient advocacy could shape future guidelines Learn more about Diabetes Connections with Stacey Simms: diabetes-connections.com ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
Continuous glucose monitoring didn’t start as sleek apps and tiny sensors — it began with chunky receivers, short wear times, and a lot of skepticism. In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman sit down with Dexcom CEO and original sensor engineer Jake Leach to trace the evolution of CGM from those early “Tylenol-shaped” receivers and repurposed pagers to today’s G7 system and beyond. They walk through the major turning points: abandoning long-term implants for subcutaneous sensors, proving that real-time CGM meaningfully improves time in range and safety, and pushing back against old-school thinking that insisted patients shouldn’t see their own data. From STS 3-Day to Seven Plus, G4, G5, G6, and now G7, Dr. Edelman, Dr. Pettus, and Jake Leach break down what each generation added — better accuracy, easier insertion, smartphone and cloud connectivity, and integration with pumps and AID systems. Most importantly, Dr. Edelman, Dr. Pettus, and Dexcom CEO Jake Leach, focus on what’s coming next and what it means for people living with diabetes today: the 15 day Dexcom G7 sensor, Smart Basal insulin titration for people with type 2 diabetes, AI-powered food logging, and the upcoming G8 platform designed to measure multiple analytes (glucose plus ketones and more) — all while pushing toward broader access and affordability. Key Topics: Early Dexcom Days & STS 3-Day: How Dexcom pivoted from implantable sensors to disposable subcutaneous CGMs and what the earliest systems were really like. Blinded vs Real-Time CGM: The ethics debate, safety implications, and studies proving real-time data improves time in range and reduces hypoglycemia. Seven Plus, G4 & G5: Major accuracy improvements, longer wear times, and the move to smartphone-based monitoring. G6 & Auto-Applicators: Eliminating mandatory calibrations and making sensor insertion faster and easier. G7 Wins & Growing Pains: Reduced size, faster warm-up, early reliability challenges, and how Dexcom addressed manufacturing and support issues. 15-Day Wear & Smart Basal: Extended wear life and CGM-guided basal insulin titration for type 2 diabetes. G8 & Multi-Analyte Sensing: A preview of Dexcom’s next-generation platform measuring glucose plus ketones and other markers. AI Food Logging & Smarter Care: Photo-based meal tracking and pairing nutrition data with glucose trends. Access & Affordability: Expanding CGM access globally and using data to reshape how diabetes care is delivered. 0:23 - Introduction & TCOYD’s 30th Anniversary 1:39 - Meet Jake Leach: 21 Years at Dexcom 3:08 - The Early Days: From Implantable Sensors to Patches 5:26 - The First Commercial CGM (STS 3-Day) & The "Pager" Receiver 8:35 - The Evolution to 7-Day Wear (Seven Plus) 10:15 - The Early Struggles with Insurance Coverage 12:32 - Why Unblinded Real-Time Data Changed Everything 16:36 - The G4 Era: Improved Accuracy & The "Share" Cradle 20:26 - G5: The Shift to Smartphone Connectivity 27:04 - Real Talk: Addressing G7 Connectivity & Sensor Failures 29:07 - Dexcom's "Unlimited Replacement" Policy for Failed Sensors 31:39 - CONFIRMED: The New 15-Day Sensor Launch 32:43 - "Smart Basal": A New Tool for Type 2 Diabetes 35:44 - G8 Reveal: Measuring Ketones, Lactate & Potassium 39:12 - New Feature: AI Smart Food Logging 41:22 - The Future of CGM: Pre-Diabetes & Heart Health 46:34 - Closing Thoughts ✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives. More diabetes resources: Website: tcoyd.org Blog: tcoyd.org/blog Podcast: tcoydthepodcast.transistor.fm Instagram: / tcoyd Facebook: / tcoyd Stay connected! Sign up for our monthly newsletter here ! Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
Get a practical breakdown of Afrezza, the ultra-rapid inhaled insulin, with this comprehensive guide to efficacy, timing, and real-world application. Join Drs. Jeremy Pettus and Steve Edelman—endocrinologists living with Type 1 diabetes—as they reveal why this unique tool is often misunderstood and how to use it effectively to flatten post-meal spikes. In this episode, we move beyond the basics to correct the biggest mistake users make regarding Afrezza dosage. If you’ve tried this therapy before and felt it "didn't work," the issue often lies in the conversion ratio. We review data from Afrezza MannKind studies (such as INHALE-3) to explain the shift from the old 1:1 ratio to the more effective 1:3 ratio. We also cover why this "rapid-on, rapid-off" insulin is the ultimate solution for exercise and how to navigate insurance coverage and prior authorizations. Topics covered in this episode: The Dosing Fix: Why you often need a higher Afrezza dosage compared to subcutaneous insulin. Speed & Kinetics: How inhaled insulin mimics the body's natural beta cells to clear glucose fast. Lifestyle Benefits: Managing "sticky highs," exercise without crashing, and dietary freedom. Safety & Screening: Spirometry requirements and who should (and shouldn't) use Afrezza. Pediatric Updates: The latest on clinical trials and potential approval for children. Whether you are managing Type 1 or Type 2 diabetes, this episode provides the practical "tips and tricks" you need to determine if Afrezza is the missing tool in your diabetes management kit Timecodes: 0:00 Start 0:24 Intro: What is Afrezza? 1:39 "Rapid On, Rapid Off" vs. Injectable Insulin 2:44 Preventing Delayed Hypoglycemia (Lows) 4:03 The Early Dosing Mistake (The 1:1 Ratio) 4:35 Jeremy’s Story: Why He Quit Using It Initially 5:44 The Correct Dosing Conversion (1:2 to 1:3) 8:09 Timing: Do You Need to Pre-Bolus? 9:16 "Follow-On" Doses for High Protein/Fat Meals 11:00 Cartridge Sizes & "Bucket" Dosing Strategy 13:10 Using Inhaled Insulin for Exercise 14:23 Real-World Test: Trix Cereal & Afrezza 15:28 Storage Tips: Fridge vs. Room Temp 16:44 Managing the Cough Side Effect 17:29 Proper Inhalation Technique 19:37 Using Afrezza with Insulin Pumps (Hybrid Closed Loop) 21:54 Pediatric Update: Is it Safe for Kids? 23:11 Why You Must Use a CGM 23:49 Lung Safety, Smokers & Spirometry Tests 24:49 How to Get It Prescribed (Overcoming Doctor Resistance) 26:27 Utilizing Trainers & Prescription Combos 29:08 Conclusion Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org **Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!** Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook | Instagram | YouTube ★ Support this podcast ★
Type 1 diabetes doesn’t always travel alone — in fact, it often brings other autoimmune conditions along for the ride. In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman shine a light on the most common ones that tend to show up with T1D, why they happen in the first place, when you should be screened, and what subtle symptoms should raise a red flag. They walk through what’s common but manageable, like thyroid issues and celiac disease — as well as what’s rare but critical not to miss, like Addison’s disease (adrenal failure) , which can be dangerous if left undiagnosed but incredibly treatable once caught early. Most importantly, Jeremy and Steve explain how simple blood tests can catch these conditions before they spiral, and how the right medication can completely change how you feel day-to-day. Key Topics: • T1D & Autoimmunity 101: Why having one autoimmune condition raises your risk for others • Thyroid Disorders: The most common — hyper vs. hypo, yearly screening, easy treatment • Celiac Disease: Why it’s up to 10x more common in T1D and often missed without symptoms • Addison’s Disease Awareness: The “silent” cortisol deficiency you don’t want to miss • Proactive Care Mindset: How to build autoimmune screening into your diabetes warranty plan (00:00) Intro: The "Raindrop" Analogy (02:26) Thyroid Disease: The Most Common T1D Link (05:25) Hypothyroidism (Low Thyroid): Symptoms & Easy Treatment (09:30) Hyperthyroidism (Graves' Disease): Symptoms & Cures (13:25) Your "Diabetes Warranty": Why You Need a Yearly TSH (14:48) Celiac Disease: The 10% Risk Factor (19:28) Celiac Screening vs. "Gluten Sensitivity" (25:31) Addison's Disease: The Other One to Know (29:43) Final Takeaway: Be Your Own Advocate Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org **Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!** Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook | Instagram | YouTube ★ Support this podcast ★
Gene therapy isn’t science fiction anymore , it’s becoming one of the most exciting frontiers in diabetes care. In this episode, Dr. Jeremy Pettus and Dr. Steve Edelman sit down with Dr. Fraser Wright, career gene therapist and Co-Founder/Chief Gene Therapy Officer at Kriya Therapeutics, to explore how gene therapy could one day help the body make its own insulin . Together, they unpack what gene therapy actually is, Dr. P’s involvement as a medical consultant for Kriya Therapeutics, how AAV (adeno-associated virus) vectors work, and what makes this “one-and-done” approach so different from traditional treatments . From success stories in blindness and hemophilia to emerging type 1 diabetes studies, the trio breaks down the science, the safety, and the hope behind this revolutionary research. You’ll learn how gene therapy has moved from rare diseases to more common ones, why the first human trials in diabetes are on the horizon, and what and what this could mean for long-term blood sugar control and independence from injections. Key Topics: Gene Therapy 101: How gene therapy differs from protein-based drugs like insulin, and why AAV vectors act as safe, engineered delivery vehicles rather than infectious viruses. Why AAV, Why Now: Seven FDA-approved AAV-based therapies have proven the potential of long-term, single-dose treatments. From Eyes to Endocrine: Lessons learned from retinal gene therapy are now guiding approaches to metabolic conditions like diabetes. The Type 1 Diabetes Approach: A muscle-targeted program aims to help the body naturally produce insulin and stabilize blood sugar levels. Control and Safety: Built-in glucose sensing and the ability to turn off gene expression ensure precision and reversibility. Real-World Considerations: How exercise, treatment site, and existing technologies like pumps or CGMs could work alongside this therapy. 0:00 – Intro: Jeremy and Steve introduce gene therapy and why this topic is a game-changer 2:15 – What gene therapy is and how it’s different from standard protein-based treatments 4:54 – Understanding AAV: safety, engineering, and why it’s the preferred delivery method 8:50 – Real-world success: seven FDA-approved AAV therapies for genetic diseases 12:20 – Lessons learned from treating blindness and how they apply to diabetes 17:40 – The Type 1 Diabetes model: using muscle tissue to produce insulin 22:15 – Managing control, glucose sensing, and preventing hypoglycemia 25:50 – Safety measures and how treatment can be reversed locally if needed 28:30 – Exercise, durability, and what animal studies reveal about real-life performance 31:10 – Timelines, trials, and what’s next for gene therapy in diabetes. What’s Ahead : Clinical trials expected to begin around 2026, offering cautious but real optimism for the future of diabetes treatment. Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org **Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!** Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook | Instagram | YouTube ★ Support this podcast ★
The diagnosis of Cushing's Syndrome is often missed because its underlying cause, hypercortisolism, masks itself as 'just diabetes,' 'just stress,' or 'just getting older,' which can lead to serious problems. In this conversation, Dr. Steve Edelman talks with a military veteran named Phil and his wife Cherese about years of unexplained fatigue, tough-to-control blood sugars, and high blood pressure, and the one test that made everything make sense. This episode discusses the early warning signs, how to advocate for answers and the hypercortisolism treatments that helped Phil feel like himself again. You’ll also hear why targeted hypercortisolism treatments and diabetes-specific approvals are on their way . You’ll learn why hypercortisolism is more common than most people realize, how it can hide behind type 2 diabetes, and what tests and treatments can make a life-changing difference. Why hypercortisolism is so often overlooked: Symptoms overlap with diabetes, stress, and other common health issues. Phil’s story of resilience: From managing diabetes with multiple medications to discovering hypercortisolism as the root cause. The partner’s perspective: How Cherese noticed the warning signs and pushed for further testing. The Catalyst Study: Why research shows up to 1 in 4 people with hard-to-control type 2 diabetes may have hypercortisolism. Diagnosis explained: The 1 mg overnight dexamethasone suppression test and why it matters. Treatment and transformation: How targeted therapies improved Phil’s blood sugars, energy, sleep, and overall quality of life. Key takeaways: Be your own best advocate—if your numbers don’t add up, it’s worth asking why. Timecodes: 0:00 – What is Cushing's Syndrome (hypercortisolism) & guest setup 0:41 – Steroids & cortisol 101: why persistently high cortisol wreaks havoc 2:01 – Phil’s backstory: diabetes diagnosis and years of “uncontrolled” numbers 4:55 – Escalating meds, rising A1C, growing fatigue—when things stop making sense 7:25 – Cherese’s Story: lifestyle overhaul, then deeper testing when sugars don’t improve 10:47 – Classic signs of Cushing's Syndrome (buffalo hump, thin arms) & sleep issues 11:23 – CATALYST study: up to 1 in 4 with tough-to-control T2D show evidence of hypercortisolism 13:10 – Diagnosing Cushing's: The hypercortisolism suppression test 16:06 – Treatment wins: targeted therapy improves glucose, mood, sleep; “new era” in care 20:45 – Takeaways: Recognizing Cushing's, self-advocacy & red flags Important Links: Cortisol in Control website: https://www.cortisolincontrol.com/ https://www.cortisolmatters.com/patient Visit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org **Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!** Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook | Instagram | YouTube ★ Support this podcast ★
